Welcome Guest | Register / Login

Pharmaceuticals Market Research Reports

The global pharmaceutical market has persistently experienced significant growth due to the ever-increasing demand for novel and more effective drugs. The reasons for this steady increase in the demand for drugs worldwide can be attributed to population growth, newer and more complex disease conditions, ageing population, and the increased prevalence of chronic and infectious diseases, some of which still remain incurable and fatal. Such numerous unmet needs and high demand rates have triggered the boost in R&D investments by key industry sectors, greatly driving the growth of this i... View more

Sort By
Title Published Price Buy Now
United Kingdom Pharmaceuticals and Healthcare Report Q4 2015
By Business Monitor International
BMI View: As a global major powerhouse in R&D and manufacturing of medicines and biotechnology, the UK will continue to present room for strong sector development, which will be further supported by the last financial year increase of for...
Sep 2015 $ 1295
Ukraine Pharmaceuticals and Healthcare Report Q4 2015
By Business Monitor International
BMI View: Ukraine's pharmaceutical market will continue to experience inflationary dynamics in 2015, as the impact of the country's economic instability and the Ukrainian hryvnia's depreciation contribute to drug price inflation. We expec...
Sep 2015 $ 1295
Philippines Pharmaceuticals and Healthcare Report Q4 2015
By Business Monitor International
BMI View: The proposed 2016 government budget will be positive for the Philippines healthcare sector. The budget proposes a significant increase in funds allocated to the Department of Health which will enable authorities to finance the e...
Sep 2015 $ 1295
Estonia Pharmaceuticals and Healthcare Report Q4 2015
By Business Monitor International
BMI View: We expect growth in Estonia's healthcare expenditure to decelerate over the long term given the country's fiscally conservative nature, the limited capacity of the national health insurer to accommodate further healthcare spendi...
Sep 2015 $ 1295
Brazil Pharmaceuticals and Healthcare Report Q4 2015
By Business Monitor International
BMI View: Continued focus on foreign investment along with the expansion of telemedicine and governmental action to improve medical access will keep Brazil and appealing destination for drugmakers and healthcare companies in coming years,...
Sep 2015 $ 1295
Botswana Pharmaceuticals and Healthcare Report Q4 2015
By Business Monitor International
BMI View: Communicable diseases will continue to dominate Botswana's disease profile, with HIV/AIDS posing the greatest burden. The government's provision of free antiretroviral treatment will provide opportunities for generic drugmakers ...
Sep 2015 $ 1295
Bahrain Pharmaceuticals and Healthcare Report Q4 2015
By Business Monitor International
BMI View: Bahrain's government will continue in its attempts at containing the rapidly expanding cost of healthcare. Private sector engagement and increasing generic substitution will continue to be employed, although government spending ...
Sep 2015 $ 1295
Uganda Pharmaceuticals and Healthcare Report Q4 2015
By Business Monitor International
BMI View: Uganda's pharmaceutical market remains dampened by poor funding and consequently underdevelopment. The private sector makes up the clear majority of pharmaceutical spending in the country in terms of value and strong private con...
Aug 2015 $ 1295
Taiwan Pharmaceuticals and Healthcare Report Q4 2015
By Business Monitor International
BMI View: Taiwan will remain a key destination for clinical trials due to the government's efforts to augment the country's medical infrastructure and streamline clinical research regulatory processes. In addition, there will be further u...
Aug 2015 $ 1295
Sweden Pharmaceuticals and Healthcare Report Q4 2015
By Business Monitor International
BMI View: Declining government reimbursement for prescription medicines and the promotion of lowervalue generic medicines does not bode well for innovative drugmakers selling their products in Western Europe, particularly as governments a...
Aug 2015 $ 1295
Sri Lanka Pharmaceuticals and Healthcare Report Q4 2015
By Business Monitor International
BMI View: The fragmented nature of the Asia Pacific region will continue to provide unequal commercial opportunities for pharmaceutical firms looking to invest in the region. Sri Lanka's pharmaceutical sector managed to attract investment...
Aug 2015 $ 1295
Peru Pharmaceuticals and Healthcare Report Q4 2015
By Business Monitor International
BMI View: Longstanding trade agreements, a growing dependence on foreign pharmaceuticals and the expansion of a national telemedicine network will continue to improve Peru's appeal to foreign investors in coming years. A rising burden of ...
Aug 2015 $ 1295
Myanmar Pharmaceuticals and Healthcare Report Q4 2015
By Business Monitor International
BMI View: Out-of-pocket payments will remain a key source of healthcare financing in Myanmar over the medium term. Central to this view will be the slow uptake of private health insurance as the sub-sector remains new to the country and h...
Aug 2015 $ 1295
Kuwait Pharmaceuticals and Healthcare Report Q4 2015
By Business Monitor International
BMI View: Kuwait's pharmaceutical sector will remain dominated by multinational drugmakers given the preference for branded products among both prescribers and consumers. Development of the local generics sector will be stimulated by the ...
Aug 2015 $ 1295
Kazakhstan Pharmaceuticals and Healthcare Report Q4 2015
By Business Monitor International
BMI View: Although pharmaceutical sales grew at a slower pace than we previously forecast in 2014, Kazakhstan's pharmaceutical market will maintain its rapid local currency growth rate over the long term. The government will continue to s...
Aug 2015 $ 1295
Jordan Pharmaceuticals and Healthcare Report Q4 2015
By Business Monitor International
BMI View: The majority of Jordan's pharmaceuticals will remain sourced from abroad despite the impressive domestic manufacturing industry. Local drugmakers will continue to supply the market with generic medicines but higher value innovat...
Aug 2015 $ 1295
Germany Pharmaceuticals and Healthcare Report Q4 2015
By Business Monitor International
BMI View: As the German economy observes signs of a tentative long-term rebalancing in which private consumption will play a more significant role in economic growth, recent improvements in high frequency indicators have lead us to an upw...
Aug 2015 $ 1295
Canada Pharmaceuticals and Healthcare Report Q4 2015
By Business Monitor International
BMI View: The second largest market in the Americas region, drugmakers operating in Canada will continue to benefit from high per capita spending on pharmaceuticals and rising public sector procurement as a result of the country's aging p...
Aug 2015 $ 1295
Bulgaria Pharmaceuticals and Healthcare Report Q4 2015
By Business Monitor International
BMI View: Strong pharmaceutical sales growth in 2015 will be moderated over the medium term by cost containment measures. Healthcare payers in Central and Eastern Europe will become increasingly assertive in using their purchasing power t...
Aug 2015 $ 1295
China Alanine Export Overlook 2014
By Think Real
China Alanine Export Overlook 2014 provides detailed analysis to identify the target commodities from customs records. The analysis service give a full view of commodities export trade records, provides comprehensive data regarding target products...
Aug 2015 $ 1000
China Tranexamic Acid Export Overlook 2014
By Think Real
China Tranexamic Acid Export Overlook 2014 provides detailed analysis to identify the target commodities from customs records. The analysis service give a full view of commodities export trade records, provides comprehensive data regarding target ...
Aug 2015 $ 1000
China Citicoline Sodium Export Overlook 2014
By Think Real
China Citicoline Sodium Export Overlook 2014 provides detailed analysis to identify the target commodities from customs records. The analysis service give a full view of commodities export trade records, provides comprehensive data regarding targe...
Aug 2015 $ 1000
China Iohexol Export Overlook 2014
By Think Real
China Iohexol Export Overlook 2014 provides detailed analysis to identify the target commodities from customs records. The analysis service give a full view of commodities export trade records, provides comprehensive data regarding target products...
Aug 2015 $ 1000
China Gliclazide Export Overlook 2014
By Think Real
China Gliclazide Export Overlook 2014 provides detailed analysis to identify the target commodities from customs records. The analysis service give a full view of commodities export trade records, provides comprehensive data regarding target produ...
Aug 2015 $ 1000
China Mefenamic acid Export Overlook 2014
By Think Real
China Mefenamic acid Export Overlook 2014 provides detailed analysis to identify the target commodities from customs records. The analysis service give a full view of commodities export trade records, provides comprehensive data regarding target p...
Aug 2015 $ 1000